Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2003
05/14/2003EP1310252A1 Injections
05/14/2003EP1310248A1 Pharmaceutical composition
05/14/2003EP1310246A2 Use of bronopol for the treatment of diseases in fish
05/14/2003EP1309860A2 Method for screening peptides for use in immunotherapy
05/14/2003EP1309721A2 Modulating multiple lineage kinase proteins
05/14/2003EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses
05/14/2003EP1309687A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309640A1 Polyurethane film-forming dispersions in alcohol-water system
05/14/2003EP1309605A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309590A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents
05/14/2003EP1309566A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309532A1 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof
05/14/2003EP1309525A2 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries
05/14/2003EP1309355A1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties
05/14/2003EP1309354A2 Therapeutic polyesters and polyamides
05/14/2003EP1309352A1 Antifungal ketoconazole composition for topical use
05/14/2003EP1309349A2 Pharmaceutical composition and method for the treatment of retroviral infections
05/14/2003EP1309348A2 Prophylactic and therapeutic monoclonal antibodies against vaccinia virus antigens
05/14/2003EP1309346A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
05/14/2003EP1309344A1 Oral solid dose vaccine
05/14/2003EP1309336A1 Derivatives of laspartomycin and preparation and use thereof
05/14/2003EP1309334A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
05/14/2003EP1309333A2 Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections
05/14/2003EP1309332A2 Macrolide formulations for inhalation and methods of treatment of endobronchial infections
05/14/2003EP1278743A4 Novel anti-infectives
05/14/2003EP1189595B1 Ophthalmic compositions in form of aqueous gels
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/14/2003EP1140987B1 Peptides for inhibiting hpv e6 proteins
05/14/2003EP1107787B1 Salmonella typhi vaccine compositions
05/14/2003EP0999856B1 Radiopharmaceuticals for imaging infection and inflammation
05/14/2003EP0815255B1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
05/14/2003EP0783319B1 Muramyl peptide compositions for inhibiting hiv replication
05/14/2003EP0692974B1 Multicomponent clostridial vaccines using saponin adjuvants
05/14/2003EP0656014B1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
05/14/2003CN1418256A Beta glucans from filamentous fungi
05/14/2003CN1418255A Herpes virus strains for gene therapy
05/14/2003CN1418253A Proteins producing altered immunogenic response and methods of making and using the same
05/14/2003CN1418248A Altered strain of modified vaccinia virus ankara (MVA)
05/14/2003CN1418220A Novel pyrazine derivatives or salts thereof, containing the derives or the salts and intermediates for the preparation of both
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1418214A 4-Hydroxy-1, 8-Naphthyridine-3-carboxamides as antiviral agents
05/14/2003CN1418194A Amide compounds and use thereof
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1418108A Parenteral use of bacterial phage associated lysing enzymes for therapeutic treatment of bacterial infections
05/14/2003CN1418102A 激素替代疗法 Hormone replacement therapy
05/14/2003CN1418097A Oxazolidinone toble formulation
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1418089A Pharmaceutical composition of glycogen phosphorylase inhibitors
05/14/2003CN1418079A Container for linezolid intravenous solution
05/14/2003CN1416901A Compound oral prepn for treating pyloric spirobacterium infection
05/14/2003CN1416894A Secreted recombinant human interferon alpha-2a injection liquid
05/14/2003CN1416888A White peony and licorice extract and its prepn process
05/14/2003CN1416887A Ointment painted to nasal cavity for preventing cold and influenza and its prepn
05/14/2003CN1416886A Skin care ointment and its prepn
05/14/2003CN1416883A Pestilence preventing Chinese medicine powder and its prepn
05/14/2003CN1416876A Antiviral Chinese medicine synergist and its prepn
05/14/2003CN1416871A Chinese medicine oral liquid for treating hepatitis and its prepn
05/14/2003CN1416867A Effective cure made of natural plant material for treating AlDS, hepatitis B, hepatitis C and cancer
05/14/2003CN1416866A Medicine for preventing and treating diseases of prawn
05/14/2003CN1416862A Gandanqing capsule
05/14/2003CN1416859A Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its prepn process
05/14/2003CN1416848A Capsule for treating chronic hepatitis B and its prepn
05/14/2003CN1416844A Cold treating medicine
05/14/2003CN1416819A Tincture for treating psoriasis and its prepn
05/14/2003CN1416815A Compound prepn containing prostaglandin E1, prostaglandin A1 and prostaglandin B1 and its prepn process and use
05/14/2003CN1416813A Application of matrine oxide in preparing medicine for treating nephrotic syndrome hemorrhagic fevor
05/14/2003CN1108294C Piperazine-2,5-dione derivatives as modulators of multidrug resistance
05/14/2003CN1108157C Gel composition for treating pulmonary tuberculosis cavity difficult to cure it
05/14/2003CN1108152C Rapamycin formulations for oral administration
05/13/2003US6563002 Biscyclopropanecarboxamide compounds and pharmaceutical use thereof
05/13/2003US6562995 Amidomethyl esters, carbonylmercaptomethyl esters, keto-containing esters, amidomethyl thioesters, amidomethyl amides, and methylene dithioesters are disclosed. The novel compounds have two carbonyl groups connected by a linking moiety having
05/13/2003US6562978 N-(3-(4-(4-(Aminocarbonyl)benzyl)-1-piperidinyl)propyl)-N-(3, 4-dichlorophenyl)-1-(methylsulfonyl)-4-piperidinecarboxamide or a salt thereof for treatment of AIDS
05/13/2003US6562960 Oligonucleotide analogues
05/13/2003US6562864 Catechin multimers as therapeutic drug delivery agents
05/13/2003US6562861 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
05/13/2003US6562846 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
05/13/2003US6562843 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders
05/13/2003US6562837 Use of tetrahydroisoquinoline compounds for the treatment of septicemia
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562823 Inhibition of farnesyl-protein transferase has been shown to block the growth of Ras-transformed cells in soft agar
05/13/2003US6562820 Method for treatment and prevention of mastitis
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562806 Pyrrolobenzodiazepines
05/13/2003US6562802 Anionic ethylene amine scavenger; and cationic, hydrophilic amine containing polymer like chitosan and derivatives, cationic polyethylenes, DEAE-4, and polyornithine
05/13/2003US6562796 Derivatives of polyene macrolides and preparation and use thereof
05/13/2003US6562792 Hygromycin derivatives
05/13/2003US6562787 Hybrid polypeptides with enhanced pharmacokinetic properties
05/13/2003US6562785 Antimicrobial agent permeabilizes bacterial but not non-bacterial cell and is sufficient to transiently permeabilize the bacteria; toxic agent is only toxic upon entry into the antibiotic resistant bacteria
05/13/2003US6562784 Indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
05/13/2003US6562376 DNA vaccines against poxviruses
05/13/2003US6562352 50 kD C fragment of tetanus toxin, P69 outer membrane protein of B. pertussis, B. pertussis filamentous haemagglutinin and carrier
05/13/2003US6562351 Fusion proteins; genetic engineering
05/13/2003US6562350 Combined vaccine against both HAV and measles virus and method of producing it
05/13/2003US6562349 Otitis media vaccine
1 ... 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 ... 1798